Abstract
Aim: To evaluate the prevalence of metabolic syndrome and analyse its corelation with metabolic and clinical parameters in patients admitted in HHMH & R, Shimla.
Material and Methods: Cross-sectional analysis was conducted at the HHMH & R, Shimla. 46 patients in total with a primary psychiatric diagnosis as per ICD 10 were included and assessed for metabolic syndrome. For diagnosing MetSNCEP criterion was applied. Chi-square was used for all the comparisons.
Results: In our observation prevalence of MetS came out to be 39.1% and was higher in males (28.2%) in comparison with females (10.8%). Prevalence was higher innon-psychotic patients (21.7%), whereas it was lesser in psychotic patients (17.4%). In patients who were on second generation antipsychotics the prevalence of metabolic syndrome was significantly higher (66%).
Conclusion: 39% of the participated hospitalized patients met the criteria for MetS and they tend to have significantly higher adiposity measures, cardiovascular markers, more likely to have comorbid conditions and history of substance use.
Keywords: Himachal Hospital of Mental Health and Rehabilitation (HHMH & R), Metabolic syndrome (MetS), Hospital for Mental Health (HMH), Second Generation Antipsychotics (SGA), Modified National Cholesterol Education Program Adult Treatment Panel III(NCEP ATP III).
References
- Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365: 1415-28.
- Isomaa BO, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes care. 2001;24:683-89.
- Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C. Definition of metabolic syndrome: Report of the national heart, lung, and blood institute/American heart association conference on scientific issues. Circulation. 2004;109:433-38.
- Cameron AJ, Shaw JE, Zimmet PZ. The metabolic syndrome: Prevalence in worldwide populations. Endocrinol Metab Clin N Am. 2004;33:351-35.
- Heiskanen T, Niskanen L, Lyytikäinen R. Metabolic syndrome in patients with schizophrenia. J Clin Psychiatry. 2003;64:575-79.
- Basu R, Brar JS, Roy Chengappa KN, John V, Parepally H, Gershon S, et al. Theprevalence of the metabolic syndrome in patients with schizoaffective disorder– bipolar subtype. Bipolar Disorders. 2004;6:314-18.
- Cohn T, Prud’ homme D, Streiner D. Characterizing coronary heart diseaserisk in chronic schizophrenia: High prevalence of metabolic syndrome. Can J Psychiatry. 2004;49:753-60.
- Kato MM, Currier MB, Gomez CM. Prevalence of metabolic syndrome in [8] Hispanic and non-Hispanic patients with schizophrenia. Prim Care Companion J Clin Psychiatry. 2004;6:74-77.
- Kumar CTS. Physical illness and schizophrenia. British Journal of Psychiatry. 2004;184:541-5.
- Ferrannini E, Haffner SM, Mitchell BD. Hyperinsulinaemia: The key feature of a cardiovascular and metabolic syndrome. Diabetologia. 1991;34:416–22.
- Abbasi F, Brown BW, Lamendola C. Relationship between obesity, insulin resistance, and coronary heart disease risk. J Am Coll Cardiol. 2002;40:937–43.
- Montague C, O’Rahilly S. The perils of portliness: Causes and consequences of visceral adiposity. Diabetes. 2000;49:883–88.
- Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation. 2005;112:2735-52.
- Mattoo SK, Mohan Singh S. Prevalence of metabolic syndrome in psychiatric inpatients in a tertiary care centre in north India. Indian Journal of Medical Research. 2010;131:46-52.
- Bressington DT, Mui J, Cheung EFC, Petch J, Clark AB, Gray R. The prevalence of metabolic syndrome amongst patients with severe mental illness in the community in Hong Kong – a cross sectional study. BMC Psychiatry. 2013;13:87-91.
- Yumru M, Savas HA, Kurt E, Kaya MC, Selek S, Savas E, et al. Atypical antipsychotics related metabolic syndrome in bipolar patients. Journal of Affective Disorders. 2007;98:247-52.
- Gupta A, Dadheech G, Yadav D, Sharma P, Gautam S. Metabolic issues in schizophrenic patients receiving antipsychotic treatment. Indian Journal of Clinical Biochemistry. 2014;29:196-201.
- Mitchell AJ, Vancampfort D, Sweers K, van Winkel R, Yu W, De Hert M. Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders—a systematic review and meta-analysis. Schizophrenia bulletin. 2013;39:306-18.
- Saenz BM, Guillena SR, de Diego BP. Comparison of metabolic syndrome between patients with severe mental disorders. European Psychiatry. 2016; 33: 283-84.
Corresponding Author
Dr Abhilaksh Kango
Psychiatrist, Himachal Hospital of Mental Health and Rehabilitation, Shimla (HP), 171005, India
DOI: https://dx.doi.org/10.18535/jmscr/v9i3.31
